CHMP recommends against Vanda's Fanaptum for schizophrenia

EMA’s CHMP recommended against approval of an MAA for Fanaptum iloperidone from Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) to treat schizophrenia. The serotonin (5-HT2) receptor and dopamine receptor a...